We are live on
!
Find out more
OPU
Omni Partners US Portfolio holdings
AUM
$1.95B
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$319M
(-14%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-18.57%
Top 10 Holdings %
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$127M |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
+$103M |
| 3 |
CVA
Covanta Holding Corporation
CVA
|
+$55.8M |
| 4 |
WBT
Welbilt, Inc.
WBT
|
+$54.6M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$49.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$234M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$111M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$90M |
| 5 |
NAV
Navistar International
NAV
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.3% |
| 2 | Technology | 15.69% |
| 3 | Industrials | 13.34% |
| 4 | Communication Services | 11.51% |
| 5 | Healthcare | 10.42% |
Similar funds
XEA
AIC
QAM
BU
H
FMW
MAFM
BOS
Omni Partners US's Q3 2021 Portfolio in Review
As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.
- Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
- Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
- Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
- Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
- Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
- Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
- Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.
Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.